A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity

A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity

Abstract Mazdutide is a once-weekly glucagon-like peptide-1 (GLP-1) and glucagon receptor dual agonist. We evaluated the efficacy and safety of 24-week treatment of mazdutide up to 6 mg in Chinese overweight adults or adults with obesity, as an interim analysis of a randomised, two-part (low doses u...

Full description

Bibliographic Details
Main Authors: Linong Ji, Hongwei Jiang, Zhifeng Cheng, Wei Qiu, Lin Liao, Yawei Zhang, Xiaoli Li, Shuguang Pang, Lihui Zhang, Liming Chen, Tao Yang, Yan Li, Shen Qu, Jie Wen, Jieyu Gu, Huan Deng, Yanqi Wang, Li Li, Han Han-Zhang, Qingyang Ma, Lei Qian
Format: Article
Language:English
Published: Nature Portfolio 2023-12-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-023-44067-4

Internet

https://doi.org/10.1038/s41467-023-44067-4

Similar Items